Catalog No.: PC-49575Not For Human Use, Lab Use Only.
Atirmociclib (PF-07220060) is a potent and selective, orally active CDK4 inhibitor with Ki of 0.6 nM (CDK4/Cyclin D1), significant sparing of CDK6 (Ki=13.9 nM CDK6/Cyclin D3).
Atirmociclib (PF-07220060) is a potent and selective, orally active CDK4 inhibitor with Ki of 0.6 nM (CDK4/Cyclin D1), significant sparing of CDK6 (Ki=13.9 nM CDK6/Cyclin D3).
1. Patent WO2019207463A1.
2. Lars Anders, et al. Cancer Res (2024) 84 (7_Supplement): ND12.
3. Palmer CL, et al. Cancer Cell. 2025 Mar 10;43(3):464-481.e14.
